Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Short-term Investments (2018 - 2019)

Apyx Medical's Short-term Investments history spans 6 years, with the latest figure at $40.9 million for Q1 2019.

  • For Q1 2019, Short-term Investments changed N/A year-over-year to $40.9 million; the TTM value through Mar 2019 reached $40.9 million, changed N/A, while the annual FY2018 figure was $61.7 million, N/A changed from the prior year.
  • Short-term Investments reached $40.9 million in Q1 2019 per APYX's latest filing, down from $61.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $61.7 million in Q4 2018 to a low of $172000.0 in Q3 2015.
  • Average Short-term Investments over 3 years is $26.5 million, with a median of $20.6 million recorded in 2015.
  • The largest YoY upside for Short-term Investments was 23.89% in 2015 against a maximum downside of 23.89% in 2015.
  • A 3-year view of Short-term Investments shows it stood at $172000.0 in 2015, then surged by 35759.3% to $61.7 million in 2018, then plummeted by 33.71% to $40.9 million in 2019.
  • Per Business Quant, the three most recent readings for APYX's Short-term Investments are $40.9 million (Q1 2019), $61.7 million (Q4 2018), and $55.5 million (Q3 2018).